Approximately 70% of advanced breast cancers are characterised by the expression of the oestrogen and/or progesterone hormone receptors (HR) and lack of overexpression of the human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ERBB2; the disease is breast carcinoma.